Carlos Malvestutto

2.1k total citations
40 papers, 672 citations indexed

About

Carlos Malvestutto is a scholar working on Infectious Diseases, Emergency Medicine and Surgery. According to data from OpenAlex, Carlos Malvestutto has authored 40 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 27 papers in Emergency Medicine and 11 papers in Surgery. Recurrent topics in Carlos Malvestutto's work include HIV-related health complications and treatments (27 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (10 papers). Carlos Malvestutto is often cited by papers focused on HIV-related health complications and treatments (27 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (10 papers). Carlos Malvestutto collaborates with scholars based in United States, Spain and Germany. Carlos Malvestutto's co-authors include Judith A. Aberg, Paul E. Klotman, Christina Wyatt, Irina Barash, Dawn Fishbein, William C. Miller, Mary E. Klotman, Jonathan Winston, Alan J. Cohen and Asher J Schranz and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Carlos Malvestutto

31 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Malvestutto United States 11 377 371 234 130 120 40 672
Robin M. Nance United States 14 245 0.6× 286 0.8× 224 1.0× 51 0.4× 115 1.0× 45 673
Valerianna Amorosa United States 18 286 0.8× 375 1.0× 346 1.5× 332 2.6× 143 1.2× 36 888
Aoife G. Cotter Ireland 14 412 1.1× 448 1.2× 149 0.6× 51 0.4× 206 1.7× 43 825
Julia Purdy United States 14 348 0.9× 236 0.6× 184 0.8× 75 0.6× 100 0.8× 23 586
S. Lawson‐Ayayi France 16 585 1.6× 526 1.4× 191 0.8× 82 0.6× 279 2.3× 30 1000
Sophia W. Chang United States 11 489 1.3× 404 1.1× 173 0.7× 62 0.5× 262 2.2× 18 899
F. Raffi France 6 304 0.8× 316 0.9× 161 0.7× 71 0.5× 139 1.2× 16 530
Paola Cicconi Italy 17 301 0.8× 489 1.3× 351 1.5× 130 1.0× 369 3.1× 45 881
Sasiwimol Ubolyam Thailand 22 374 1.0× 865 2.3× 463 2.0× 108 0.8× 706 5.9× 84 1.3k
Antonio Antela Spain 18 330 0.9× 678 1.8× 391 1.7× 193 1.5× 362 3.0× 49 947

Countries citing papers authored by Carlos Malvestutto

Since Specialization
Citations

This map shows the geographic impact of Carlos Malvestutto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Malvestutto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Malvestutto more than expected).

Fields of papers citing papers by Carlos Malvestutto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Malvestutto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Malvestutto. The network helps show where Carlos Malvestutto may publish in the future.

Co-authorship network of co-authors of Carlos Malvestutto

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Malvestutto. A scholar is included among the top collaborators of Carlos Malvestutto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Malvestutto. Carlos Malvestutto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grinspoon, Steven, Markella V. Zanni, Virginia A. Triant, et al.. (2025). Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE. The Lancet HIV. 12(2). e118–e129. 9 indexed citations
2.
Smith, Emma, Carlos Malvestutto, Heather J. Ribaudo, et al.. (2025). Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort. Open Forum Infectious Diseases. 12(4). ofaf177–ofaf177.
3.
Grinspoon, Steven, Estebán Martínez, Carl J. Fichtenbaum, et al.. (2025). Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2. Clinical Infectious Diseases. 82(2). e248–e257.
4.
Lu, Michael T., Heather J. Ribaudo, Sara McCallum, et al.. (2025). Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy. JACC Advances. 4(6). 101781–101781. 1 indexed citations
5.
Kolossváry, Márton, Irini Sereti, Markella V. Zanni, et al.. (2025). Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV. Journal of Clinical Investigation. 135(22).
6.
Fichtenbaum, Carl J., Carlos Malvestutto, Maya Watanabe, et al.. (2025). Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis. The Lancet HIV. 12(7). e496–e505.
7.
deFilippi, Christopher R., Sara McCallum, Markella V. Zanni, et al.. (2024). Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV. SHILAP Revista de lepidopterología. 3(9). 101206–101206. 3 indexed citations
8.
Bhattacharya, Romit, Md Mesbah Uddin, Aniruddh P. Patel, et al.. (2024). Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood Advances. 8(4). 959–967. 5 indexed citations
9.
Erlandson, Kristine M., Triin Umbleja, Heather J. Ribaudo, et al.. (2024). Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function. Clinical Infectious Diseases. 80(2). 425–433. 1 indexed citations
10.
Overton, Edgar T., Amy Kantor, Kathleen V. Fitch, et al.. (2024). Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV. AIDS. 39(1). 31–39.
11.
Malvestutto, Carlos, et al.. (2024). Beyond the Numbers: Weight Gain Risk Factors, Implications, and Interventions among Individuals with HIV. 6(1). 1–10. 1 indexed citations
12.
Kolossváry, Márton, Christopher R. deFilippi, Sara McCallum, et al.. (2023). Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV. EBioMedicine. 90. 104538–104538. 2 indexed citations
13.
Taylor, Lauren, et al.. (2023). Weight Gain in People with HIV: The Role of Demographics, Antiretroviral Therapy, and Lifestyle Factors on Weight. AIDS Research and Human Retroviruses. 39(12). 652–661. 1 indexed citations
14.
Malvestutto, Carlos. (2022). The Evolving Landscape of ASCVD Risk Among Patients With HIV. The Journal of Family Practice. 71(6 Supplement). S58–S62. 1 indexed citations
15.
16.
17.
Grinspoon, Steven, Kathleen V. Fitch, Edgar T. Overton, et al.. (2019). Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). American Heart Journal. 212. 23–35. 89 indexed citations
18.
Malvestutto, Carlos & Judith A. Aberg. (2013). Challenges of Statins in HIV Hyperlipidemia. US Endocrinology. 9(2). 157–157. 1 indexed citations
19.
Wyatt, Christina, Carlos Malvestutto, Steven G. Coca, Paul E. Klotman, & Chirag R. Parikh. (2008). The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS. 22(14). 1799–1807. 82 indexed citations
20.
Tedaldi, Ellen, Katherine Huppler Hullsiek, Carlos Malvestutto, et al.. (2003). Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases. 36(10). 1313–1317. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin M. Nance Breakdown of academic impact, for papers by Valerianna Amorosa Breakdown of academic impact, for papers by Aoife G. Cotter Breakdown of academic impact, for papers by Julia Purdy Breakdown of academic impact, for papers by S. Lawson‐Ayayi Breakdown of academic impact, for papers by Sophia W. Chang Breakdown of academic impact, for papers by F. Raffi Breakdown of academic impact, for papers by Paola Cicconi Breakdown of academic impact, for papers by Sasiwimol Ubolyam Breakdown of academic impact, for papers by Antonio Antela
Rankless by CCL
2026